Blueprint Medicines Corporation (BPMC) - Stock Analysis

LOS ANGELES, CA / ACCESSWIRE / August 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Blueprint Medic... Get a real-time Blueprint Medicines Corporation (BPMC) stock price quote with breaking news, financials, statistics, charts and more.

CouponFollow Extension

$115
OFF

Blueprint Medicines (BPMC) Stock Price, News & Analysis

1 week from now

3 days ago · Blueprint Medicines (BPMC) raised $115 million in an initial public offering on Thursday, April 30th 2015. The company issued 7,200,000 shares at a price of $15.00-$17.00 per share. Goldman Sachs and Cowen and Company acted as the underwriters for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

marketbeat.com

95%
OFF

Blueprint Medicines Stock Forecast - Stock Analysis

1 week from now

Nov 6, 2024 · The 18 analysts with 12-month price forecasts for Blueprint Medicines stock have an average target of 120.5, with a low estimate of 76 and a high estimate of 168. The average target predicts an increase of 20.95% from the current stock price …

stockanalysis.com

$128
OFF

Key Takeaways From Blueprint Medicines Analyst Ratings

1 week from now

2 days ago · Blueprint Medicines (NASDAQ:BPMC) ... analysts have established 12-month price targets, indicating an average target of $128.0, along with a high estimate of $151.00 and a low estimate of $88.00 ...

nasdaq.com

75%
OFF

Blueprint Medicines Stock Price History - Stock Analysis

1 week from now

Oct 25, 2024 · Get a complete stock price history for Blueprint Medicines, starting from its first trading day. Includes open, high, low, close and volume. ... Stock Analysis Pro. Watchlist. Collapse. Blueprint Medicines Corporation (BPMC) NASDAQ: BPMC · Real-Time Price · USD. Watchlist Compare. 82.47-0.62 (-0.75%) Oct 25, 2024, 4:00 PM EDT - Market closed.

stockanalysis.com

29%
OFF

Blueprint Medicines (Nasdaq:BPMC) - Stock Price, News & Analysis ...

1 week from now

Nov 7, 2024 · Blueprint Medicines Corporation to Report Q4, 2023 Results on Feb 15, 2024. Blueprint Medicines Corporation (NASDAQ:BPMC) Shares Could Be 29% Below Their Intrinsic Value Estimate. Subdued Growth No Barrier To Blueprint Medicines Corporation (NASDAQ:BPMC) With Shares Advancing 38%.

simplywall.st

$6.96
OFF

Blueprint Medicines (NASDAQ:BPMC) Given Buy Rating At

1 week from now

2 days ago · Read Our Latest Analysis on Blueprint Medicines. Blueprint Medicines Stock Performance. Shares of NASDAQ:BPMC traded down $6.96 on Friday, hitting $88.69. 1,001,074 shares of the company were exchanged, compared to its average volume of 692,935. The company has a debt-to-equity ratio of 1.09, a quick ratio of 3.27 and a current ratio of 3.32.

marketbeat.com

$130.00
OFF

Blueprint Medicines (NASDAQ:BPMC) Stock Rating Upgraded By

1 week from now

Nov 8, 2024 · Guggenheim increased their price target on Blueprint Medicines from $130.00 to $138.00 and gave the company a "buy" rating in a report on Friday, August 2nd. ... Read Our Latest Stock Analysis on BPMC. ... Blueprint Medicines Stock Down 0.6 %. Shares of BPMC stock traded down $0.56 on Friday, hitting $100.83. The company's stock had a trading ...

marketbeat.com

$96.88
OFF

JPMorgan Chase & Co. Initiates Coverage On Blueprint Medicines …

1 week from now

3 days ago · Read Our Latest Stock Analysis on Blueprint Medicines Blueprint Medicines Trading Up 0.3 %. Shares of NASDAQ:BPMC opened at $96.88 on Thursday. The firm has a fifty day moving average of $89.46 and a two-hundred day moving average of $98.91. The company has a quick ratio of 3.27, a current ratio of 3.32 and a debt-to-equity ratio of 1.09.

marketbeat.com

FAQs about Blueprint Medicines Corporation (BPMC) - Stock Analysis Coupon?

What is the upside for Blueprint medicines (BPMC) stock?

16 analysts have issued twelve-month price objectives for Blueprint Medicines' stock. Their BPMC share price forecasts range from $38.00 to $114.00. On average, they predict the company's stock price to reach $72.68 in the next year. This suggests a possible upside of 65.2% from the stock's current price. ...

What is the price of BPMC blueprint medicines Corporation (BPMC)?

BPMC Blueprint Medicines Corporation Stock Price & Overview Follow $86.470.86(+1.00%)4:00 PM 10/22/24 NASDAQ |$USD |Post-Market:$86.475:33 PM Summary Ratings Financials Earnings Dividends Valuation Growth Profitability Momentum Peers Options Charting All Analysis Comments News Transcripts SEC Filings Press Releases Related Analysis BPMC Stock Price ...

Is blueprint medicines a good stock to buy?

Blueprint Medicines has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 7 buy ratings, 7 hold ratings, and 1 sell rating. According to analysts' consensus price target of $72.68, Blueprint Medicines has a forecasted upside of 66.7% from its current price of $43.61. ...

Does NASDAQ use the BPMC stock value to determine compliance?

NASDAQ does not use this value to determine compliance with the listing requirements. Blueprint Medicines Corporation Common Stock (BPMC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ...

Where can I buy BPMC stock?

Shares of BPMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. ...

Who is blueprint medicines?

As of Jan 31, 2024. Values delayed up to 15 minutes Blueprint Medicines Corporation is a global precision therapy company that is inventing medicines for people with cancer and blood disorders. ...